Cumulus 'to revolutionise fight against neurodegenerative disease'

Cumulus Neuroscience closes £3.25M funding round

Belfast-based digital health technology company Cumulus Neuroscience has successfully closed a £3.25 million equity funding round that will be used to scale up its commercial operations.

Belfast's Cumulus Neuroscience closes £3m round

Cumulus Neuroscience, a health tech company based out of Belfast, has secured a £3.25m investment to advance the commercialisation of its brain assessment technology. The company works with biopharma partners to provide a suite of tools to support the development of neurological treatments. Its flagship product is its EEG headset (pictured), used to scan and analyse brain functions, assessing functions such as cognition, mood and language. Cumul…

Cumulus 'to revolutionise fight against neurodegenerative disease'

Belfast-based HealthTech Cumulus Neuroscience has raised a £3.25m equity funding round to scale up its commercial operations. The company has a team of 31 staff and is headquartered at Catalyst in Belfast’s Titanic Quarter and the funding will also be used to hire key personnel, including a head of B2B marketing and sales operations as well as a VP of business development. The funding round was led by a £1.5m investment from Whiterock’s Growth C…